Literature DB >> 33868652

Gadolinium Deposition and Liver MRI.

Robert M Marks1,2, Ryan M Ash3, James T Lee3,4.   

Abstract

Entities:  

Year:  2021        PMID： 33868652      PMCID： PMC8043711          DOI： 10.1002/cld.1024

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  17 in total

Review 1.  Magnetic resonance imaging of liver tumors.

Authors:  Riccardo Lencioni; Dania Cioni; Laura Crocetti; Clotilde Della Pina; Carlo Bartolozzi
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

2.  Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism.

Authors:  Blayne Welk; Eric McArthur; Sarah A Morrow; Penny MacDonald; Jade Hayward; Andrew Leung; Andrea Lum
Journal:  JAMA       Date:  2016-07-05       Impact factor: 56.272

3.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

4.  Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.

Authors:  Y Forslin; S Shams; F Hashim; P Aspelin; G Bergendal; J Martola; S Fredrikson; M Kristoffersen-Wiberg; T Granberg
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

5.  Gadolinium Deposition Disease: A New Risk Management Threat.

Authors:  H Benjamin Harvey; Vrushab Gowda; Glen Cheng
Journal:  J Am Coll Radiol       Date:  2019-11-27       Impact factor: 5.532

Review 6.  Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer.

Authors:  Mahan Mathur; Jason R Jones; Jeffrey C Weinreb
Journal:  Radiographics       Date:  2019-12-06       Impact factor: 5.333

7.  Do Gadolinium-Based Contrast Agents Affect 18F-FDG PET/CT Uptake in the Dentate Nucleus and the Globus Pallidus? A Pilot Study.

Authors:  Kyle Bauer; Alaina Lathrum; Osama Raslan; Patrick V Kelly; Yihua Zhou; Debra Hewing; Crystal Botkin; James A Turner; Medhat Osman
Journal:  J Nucl Med Technol       Date:  2016-11-10

8.  Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.

Authors:  Wendell A Gibby; Krissa A Gibby; W Andrew Gibby
Journal:  Invest Radiol       Date:  2004-03       Impact factor: 6.016

9.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Authors:  Tomonori Kanda; Kazunari Ishii; Hiroki Kawaguchi; Kazuhiro Kitajima; Daisuke Takenaka
Journal:  Radiology       Date:  2013-12-07       Impact factor: 11.105

10.  Effect of different doses of gadolinium contrast agent on clinical outcomes in MS.

Authors:  Nathalie Ackermans; Carolyn Taylor; Roger Tam; Robert Carruthers; Shannon Kolind; Heejun Kang; Mark S Freedman; David Kb Li; Anthony L Traboulsee
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-02-16
View more
  1 in total

Review 1.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.